Erschienen in:
30.04.2016 | Knee
Comparison of long-term clinical outcomes after bilateral mobile-bearing total knee arthroplasties using PCL-retaining and PCL-substituting implants in the same patients
verfasst von:
Yoshinori Ishii, Hideo Noguchi, Junko Sato, Tetsuya Sakurai, Shin-ichi Toyabe
Erschienen in:
Knee Surgery, Sports Traumatology, Arthroscopy
|
Ausgabe 12/2017
Einloggen, um Zugang zu erhalten
Abstract
Purpose
Whether the posterior cruciate ligament (PCL) should be retained or substituted in total knee arthroplasty (TKA) remains an issue of concern. The purpose of this study was to perform within-patient comparisons of mid- and long-term clinical outcomes after mobile-bearing TKA using PCL-retaining (PCLR) and PCL-substituting (PCLS) implant designs.
Methods
Clinical outcomes were assessed in thirty-eight patients (76 knees) who underwent bilateral scheduled staged TKA with a PCLR design on one side and a PCLS design on the other. Median follow-up periods were 118 months (range 60–211) and 114 months (62–198) in knees with PCLR and PCLS implants, respectively. The preoperative diagnosis for all patients was osteoarthritis. The postoperative clinical results of mobile-bearing TKAs using PCLR and PCLS implant designs were evaluated.
Results
The postoperative Hospital for Special Surgery and the new Knee Society Knee Scoring System scores revealed no differences between PCLR and PCLS implant designs. Postoperative flexion and extension also did not differ between designs. Postoperative median femorotibial alignment was 4° for PCLR and 5° for PCLS implants, respectively; this difference was not significant. Six of the knees with PCLR and three of the knees with PCLS implants had radiolucent lines around the tibial prostheses; these were less than 1 mm and nonprogressive.
Conclusions
Clinically good results were obtained at approximately 10 years after mobile-bearing TKA using both PCLR and PCLS implant designs bilaterally in the same patients. These results provide conclusive evidence that equivalent clinical results can be obtained with either implant design.
Level of evidence
Therapeutic study, Level II.